Advanced search
Publication Cover
Leukemia & Lymphoma Volume 62, 2021 - Issue 3
Submit an article Journal homepage
2,032
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

Tyrosine kinase inhibitor treatment discontinuation in chronic myeloid leukemia: patient views

Vashti N. M. F. Trompa Department of Clinical Pharmacology and Pharmacy, Amsterdam Public Health Research Institute, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The NetherlandsCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-6086-0668
ORCID Icon,
Lonneke Timmersa Department of Clinical Pharmacology and Pharmacy, Amsterdam Public Health Research Institute, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
,
Leanne Koningena Department of Clinical Pharmacology and Pharmacy, Amsterdam Public Health Research Institute, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
,
Jeroen J. W. M. Janssenb Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands
,
Peter E. Westerweelc Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, The NetherlandsORCID Iconhttps://orcid.org/0000-0002-0746-7039
ORCID Icon,
Inge G. P. Geelenc Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, The Netherlands
,
Jan de Jongd Hematon Foundation, Utrecht, The Netherlands
,
Jan J. Beckeringhe Westwijk Health Centre, Amstelveen, The Netherlands
,
Christel C. L. M. Boonsa Department of Clinical Pharmacology and Pharmacy, Amsterdam Public Health Research Institute, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
&
Jacqueline G. Hugtenburga Department of Clinical Pharmacology and Pharmacy, Amsterdam Public Health Research Institute, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
 show all
Pages 649-658 | Received 30 Jun 2020, Accepted 13 Oct 2020, Published online: 06 Nov 2020

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Ilaria Cutica, Silvia Riva, Ester Maria Orlandi, Alessandra Iurlo, Claudia Vener, Chiara Elena, Cristina Bucelli, Daniele Cattaneo, Elisa Tomezzoli & Gabriella Pravettoni. (2022) Psychological Factors Affecting the Willingness to Accept a Possible Tyrosine Kinase Inhibitor (TKI) Discontinuation in Chronic Myeloid Leukaemia (CML) Patients. Patient Preference and Adherence 16, pages 2963-2975.
Read now

Articles from other publishers (2)

Adrhyann Jullyanne de Sousa Portilho, Emerson Lucena da Silva, Emanuel Cintra Austregésilo Bezerra, Carinne Borges de Souza Moraes Rego Gomes, Vitor Ferreira, Maria Elisabete Amaral de Moraes, David Rodrigues da Rocha, Rommel Mário Rodriguez Burbano, Caroline Aquino Moreira-Nunes & Raquel Carvalho Montenegro. (2022) 1,4-Naphthoquinone (CNN1) Induces Apoptosis through DNA Damage and Promotes Upregulation of H2AFX in Leukemia Multidrug Resistant Cell Line. International Journal of Molecular Sciences 23:15, pages 8105.
Crossref
Anthi Petrou, Maria Fesatidou & Athina Geronikaki. (2021) Thiazole Ring—A Biologically Active Scaffold. Molecules 26:11, pages 3166.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.